Over 120 U.S.-funded biolabs across 30+ countries, including 25–30 in war-torn Ukraine, conduct high-risk research on dangerous pathogens like anthrax and coronaviruses, raising global health security concerns due to potential breaches in conflict zones.
U.S. funding for GOF research—engineering pathogens to enhance transmissibility or virulence—is highlighted as a catastrophic global risk, despite a 2025 executive order banning such work domestically, leaving foreign labs unchecked and ethically questionable.
The Ukraine biolabs face existential threats from the Russia-Ukraine war, with Russian strikes on infrastructure increasing risks of accidental or deliberate pathogen release amid silence from U.S. officials.
Decades of secrecy, denial, and discrediting critics (e.g., labeling them “disinformation peddlers”) underscore systemic opacity, particularly around the 2020 pandemic’s origins and lab-leak scenarios, eroding public trust in agencies like the CDC and WHO.
Gabbard’s revelations demand an end to GOF funding, independent oversight of labs, and public disclosure of research protocols to prevent future pandemics or bioweapon incidents, challenging globalist agendas and corporate interests profiting from biosecurity gaps.
In a groundbreaking revelation, Director of National Intelligence Tulsi Gabbard has exposed a shadowy network of over 120 U.S.-funded biolabs spanning more than 30 countries, including 25 to 30 in war-torn Ukraine. These facilities, some of which house deadly pathogens, face existential risks due to the ongoing Russia-Ukraine conflict, raising urgent questions about global health security. Gabbard’s disclosure follows months of intelligence community research and comes amid a history of government secrecy and public deception about biolab activities. The exposure of this program, which includes high-risk Gain-of-Function research, underscores the need for transparency in an era where bioweapons and pandemic threats loom large.
Read Full Article: https://www.naturalnews.com/2026-06-13-dni-gabbard-unveils-scope-us-funded-biolabs.html
